New Kidney Drug Therapy and the FDA  The American Association of Kidney Patients, the largest kidney patient consumer and caregiver organization in the nation, today issued the following statement regarding the recent approval by the U.S. Food and Drug Administration of a new drug therapy, Kerendia by Bayer Pharmaceuticals, designed to slow chronic kidney disease … Continue reading FDA Approval Of Kerendia To Help Slow Kidney Disease And Failure Associated With Type 2 Diabetes